This was a stupid buy, I didn't look analyze the charts long enough and eventually got stopped out at the 4ema. If you look at the previous runs throughout the year similar news was released, it popped the day of then tapered back. There was one key word that convinced me to buy, "stops" cancer. No clinical references to back up the claim. It might see some more action today went R/G at close, but nothing that will be permanent over the next couple of days.